首页|丁苯酞胶囊辅助依达拉奉治疗急性脑梗死的效果及对患者神经功能、预后的影响

丁苯酞胶囊辅助依达拉奉治疗急性脑梗死的效果及对患者神经功能、预后的影响

扫码查看
目的 探究急性脑梗死患者采用丁苯酞胶囊联合依达拉奉治疗的效果及对神经功能、预后的影响.方法 选取聊城市脑科医院 2021 年1 月—2022 年 1月收治的 200 例急性脑梗死患者为研究对象,按随机数字表法将其分为对照组和观察组,每组 100 例.对照组采用依达拉奉治疗,观察组在对照组基础上采用丁苯酞治疗,均持续 2 周.对比两组患者的神经功能、临床疗效、凝血功能、预后情况及不良反应发生情况.结果 观察组的治疗总有效率为 97.00%,高于对照组的 88.00%,差异有统计学意义(P<0.05).治疗后,观察组的美国国立卫生研究院卒中量表评分低于对照组,差异有统计学意义(P<0.05).治疗后,观察组的凝血酶原时间、活化部分凝血活酶时间、凝血酶时间均长于对照组,纤维蛋白原水平低于对照组,组间差异有统计学意义(P<0.05).治疗后,观察组的改良Rankin量表评分低于对照组,差异有统计学意义(P<0.05).两组的不良反应发生率比较,差异无统计学意义(P>0.05).结论 采用丁苯酞胶囊辅助依达拉奉治疗急性脑梗死,能够有效减轻患者神经功能损害,改善凝血功能及预后,且安全性高.
Effect of Butylphthalide Capsules Combined with Edaravone in the Treatment of Acute Cerebral Infarction and Its Impact on Patients'Neurological Function and Prognosis
Objective To investigate the therapeutic effect of butylphthalide capsule combined with edaravone in the treatment of acute cerebral infarction and its impact on patients'neurological function and prognosis.Methods A total of 200 patients with acute cerebral infarction admitted to Liaocheng Brain Hospital from January 2021 to January 2022 were selected as the research objects and were divided into a control group and an observation group according to random number table method,with 100 cases in each group.The control group was treated with edaravone,and the observation group was treated with butylphthalide capsule on this basis.Both groups were treated for 2 weeks.The neurological function,clinical efficacy,coagulation function,prognosis and adverse reactions were compared between the two groups.Results The total effective rate of the observation group was 97.00%,which was higher than 88.00%of the control group,the difference was statistically significant(P<0.05).After treatment,the National Institute of Health Stroke Scale score of the observation group was lower than that of the control group,and the difference was statistically significant(P<0.05).After treatment,the prothrombin time,activated partial thrombin time and thrombin time in the observation group were longer than those in the control group,and the fibrinogen level was lower than that in the control group,the differences between the groups were statistically significant(P<0.05).After treatment,the modified Rankin scale score of the observation group was lower than that of the control group,and the difference was statistically significant(P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion The use of butylphthalide capsule combined with edaravone in the treatment of acute cerebral infarction can effectively reduce patients'neurological damage,improve their coagulation function and prognosis,and has high safety.

Acute cerebral infarctionButylphthalideEdaravoneNeurological functionCoagulation functionPrognosis

梁阳阳、陈燕玲

展开 >

聊城市脑科医院神经内科,山东聊城 252000

急性脑梗死 丁苯酞 依达拉奉 神经功能 凝血功能 预后情况

2024

反射疗法与康复医学

反射疗法与康复医学

ISSN:
年,卷(期):2024.5(9)
  • 9